Marks David L, Olson Rachel Lo, Fernandez-Zapico Martin E
Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
University of Minnesota Rochester, Rochester, MN 55904, USA.
Epigenomics. 2016 Dec;8(12):1671-1687. doi: 10.2217/epi-2016-0110. Epub 2016 Oct 4.
Stromal cells of the tumor microenvironment have been shown to play important roles in both supporting and limiting cancer growth. The altered phenotype of tumor-associated stromal cells (fibroblasts, immune cells, endothelial cells etc.) is proposed to be mainly due to epigenetic dysregulation of gene expression; however, only limited studies have probed the roles of epigenetic mechanisms in the regulation of stromal cell function. We review recent studies demonstrating how specific epigenetic mechanisms (DNA methylation and histone post-translational modification-based gene expression regulation, and miRNA-mediated translational regulation) drive aspects of stromal cell phenotype, and discuss the implications of these findings for treatment of malignancies. We also summarize the effects of epigenetic mechanism-targeted drugs on stromal cells and discuss the consideration of the microenvironment response in attempts to use these drugs for cancer treatment.
肿瘤微环境中的基质细胞已被证明在支持和限制癌症生长方面都发挥着重要作用。肿瘤相关基质细胞(成纤维细胞、免疫细胞、内皮细胞等)的表型改变主要被认为是由于基因表达的表观遗传失调;然而,只有有限的研究探讨了表观遗传机制在调节基质细胞功能中的作用。我们综述了最近的研究,这些研究展示了特定的表观遗传机制(基于DNA甲基化和组蛋白翻译后修饰的基因表达调控,以及miRNA介导的翻译调控)如何驱动基质细胞表型的各个方面,并讨论了这些发现对恶性肿瘤治疗的意义。我们还总结了靶向表观遗传机制的药物对基质细胞的影响,并讨论了在尝试使用这些药物进行癌症治疗时对微环境反应的考虑。